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taken at the time of combined heart-lung transplant. ATI and AT2 receptor
binding were determined by competitive displacement with the ATI receptor
antagonist Iosarfan. Comparison was made to nonfailing, nordransplantsd
@nor hearts.
Group ACEBIIW TotslATR AT, AT2
PPH LV (n = 8) 712 &S6* 9.93* 1.44 6.41 + 1.23 3,52 + 0,55
PPHRV~n=6) 6S7+ 136* 5.37k l.O@ 2.37* 0.5#.* 3.00+ 0.76
NFLVh = 2S-28) 341*2S 7.66+ 0.53 5.27+0.50 2.39+0.30
NFRV\n .S-11)” 344+53 10.2* 1.20 7.46* 1.00 2.79 + 0.41
Readte shownare mean k SE fmolrmgproteinfor all catsgoriso.NF= nonfallingdonor
heart;LV= Isftventriole;RV= rightventricle.*p <0.05 va.NFLV:~p<0.05 vs.PPHLV;
*P< 0.05vs,NFFIV(ANOVA).
Conclusions: 1) ACE binding sites were increased in both RV and LV of
PPH hearts comparsd to NF RVand NF LV;2) ATI receptorswere selectively
decreased in PPH RV compared to PPH LV and NF RV.These data suggest
that systemic mechanisms regulate ACE whereas local factors related to
pressure overload of the RV modulate ATI receptor deneify in PPH.
a976154 TheEffectsof AntihypertenslveDrugsonSusceptibilityto VentricularArrhythmia,
Regraaaionof LeftVentricularHypertrophy,of
CerdiacFibroeieandPostinfarctionMortaiity
T. Nguyen, J.L. Rouleau. Monlreal Heart Institute, Montreal, Quebec,
Canatia
Hypertension and left ventricular hypettrophy (LVH) are known to increase
the riak of ventricular arrhythmias (VA) and the risk of dying during an
aoute myocardial infarction (Ml). In this study, We assessed the effects of
3 antihypettensive drugs on regression of LVH and cardiac fibrosis (CF),
inducibility of VA and survival post Ml in 86 male spontaneous hypertensive
rats with evidence of LVH. Twenty-five served as controls (Ctl); 20 received
Captopril (Cap) which normalized systolic biood pressure (BP), reduced LVH
and CF, 20 received Propranolol (Pro) which reduced heart rate (HR) but
did not reduce BP or LVH and 21 received Hydralszine (Hyd) which lowered
BP, reduced slightly LVH and CF. After 12 weeks of therapy, medications
were stopped for 72 hra prior to Programmed Electrical Stimulation (PES).
Immediately after PES, an acute Ml was produced by ligation of the LAD at
ite origin and survival at 3 hrs was evaluated.
Gr (n) BP [mmHg) HR (bpm) LV/TB VA CF (%) CF Mortality
.,
week 12 “ week ~2” (mg/g) (o/o) vol. dens. Total. (%)
Ctl (25) 193 i 12 501 &28 2.6+ 0.1 35 3.2 + 1.1 9.0 71
Pro 120) 165 &12 337* 22* 2.6 k 0.3 11+ 2.3+ 0.6” 6.4* 70
cap’f2s) 83* 14* 496+45 2.2+0.2” 5* 2.0 * 0.7” 4,4’ 40*
Hyd (21) 126+ 13* 531 + 16* 2.6+ 0.2” 25 2.9 + 0.9” 7.6 67
LVrTB=lettventricular/tOtalbdY weight;CFtOtat=CFvOL derwityx LVrTB(OAgrmg).*p
<0.05, +p <0.1 vs controlby ANOVA
According to the results, Cap significantly decreased inducibility of VA,
whereas Hyd tendad to reduce CF but did not significantly reduce LVH
suggesting that marked rather than mild regression of LVH ia neceasaty
in order to improve survival in this model. Thus, the morphologic changes
that accompany the hypotension effects of Cap result in a decrease ‘in
susceptibility to arrhythmias and peri-infarcf mortality.
at Columbia (CPMC) (7/93-10/95), and included serum Na+, reating HR,
LVEF,mean BP,peak V02, ischemic etiology and QRS z 120 maec. SD and
nonsudden cardiac death (NSCD) groups were compared by Wilooxon and
t-tests. Kaplan-Meier freedom from SD and NSCD were determined, with
URGTXP considered a NSCD. Predictions of any event, SD and NSCD at 1
year were assessed by determining the areas under the ROC cuwe (AUC).
Freedom from SD @ l-year was 92 + 2% (HUP), 93 + 2% (CPMC).
Freedom from NSCD @ 1 year was 84 & 2% (HLJP),75 + 3% (CPMC).
Most clinicel characteristics were similar in SD and NSCD patients. There
were no differences between groupe for NYHA class, cardiac index or 6 of 7
model variables. Peak V02 (ml/kg/min) tended to be higher for patients with
SD (14.6 + 5.2 VS. 12.5 + 3.9, p = 0.04 [HUP]; 15.9 + 4.8 VS.13.9 + 3.4,
p = 0.06 [CPMC]). Overall discrimination for event-free suwival (AUC = 0.81
[HUP], 0.79 [CPMC]) and NSCD (0.82+ 0.04 [HUP], 0.78 + 0.04 [CPMC])
was good. AUC for SD was slightly worse (0,75 + 0.05 [HUP], 0.66 & 0.08
[CPMC]).
In conclusion, the incidence of sudden death was quite low in both sam-
ples. The model was highly effective overall, but more effective in identifying
patients who died a NSCDthan it was in identifying patients who died a SCD.
Further investigation is needed todevelopa specific model to predict sudden
cardiac death.
m977156 TheNatureiHistoryof HeartFaiiureWithPreservedLeftVentricularSyetoiicFunction
E.F.Philbin, T. Erb, P.Jenkins. Maasachusetis General Hospital, Boston,
MA, USA, Bassefi Rasearch institute, Cooperstown, NE USA
To determine whether elderly heart failure (HF) patients with preserved LV
systolic function (diastolic HF) treated in the community have a prognosis
different than those with impaired LV contractility, we screened 1,402 con-
secutive patients admitted to 10 non-university hospitals and identified 801
whose LV function was assessed, Patients were followed prospectively for
8 months after discharge; death, hospital readmission and functional status
were tracked. Diastolic HF. present in 45Y0,was defined as clinical HF with
an LV ejection fraction (EF) ?40% or qualitatively normal LV contractility.
The rehospitalization rate was 43%; the cumulative death rate, 22%. The
groups differed in gender mix, age, serum sodium, hematocrit, prevalence of
cardiomsgaly and ventricular arrhythmia, and the use of certain medications.
Outcomeewere stratified by LVfunotion and adjustad for differences between
the groups. The risk-adjusted odds ratios for death and/or rehospitalization
associated with diastolic I-IFare shown:
Endooint Odds Ratio Confidence Interv D
All-causemortality 0.660 0.446-0.977
CHF death
0.036
0.680 0.403-1.146 0,147
Any rehospitalization 1.153 0.647-1.569 0.365
CHF rehospitalization 0.876 0.605-1.26S o.4e3
Death orrehospitalization 0.957 0.703-1.302 0.776
Mean hospital length of stay, rnpatient death rates, and pest-discharge
functional status measures were not different between the groups. Though
limited by small sample size, this study suggests that the risk-adjusted 6-
month death rate in the elderly with HF treated in the community is lower
among those with diastolic HF than those with systolic disease. These find-
ings support recommendations that LV function be measured in HF for ita
prognostic value.
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m977155 PredictingModeof DeathinAdvancedHeartFaiiure:Performanceofa ModeiDasignedto
PredictSurvivaiin PatientsReferredfor
TransplantEvacuation
K.D. Aaronson, D.M. Mancini. Division of C/rcu/atoryPhysiology, Columbia
Univerai~ New York,NY USA
We investigated whether a previously developed statistical model to predict
event-free survival (no death or urgent transplant [URGTXP]) in ambulatory
patients with CHF referred for TXP evaluation could be used to predict
sudden cardiac death (SCD).
The model was developed from 268 ambulatory patients with advanced
CHF at the Univ. of Penn. (HUP) (7/6&l/93) and validated on 199 patients
1977-1571 AiterationofPhyaicianBehaviorinthe Careof
CongestiveHeartFaiiurePatientsin the
CommunityHospiteiSettingUeingAmerican
Coiiegeof Cardiology/AmericanHeart
AssociationGuidelines
R.A. Rauh, N.J. Schwabauer, EL. Enger, J.F. Moran. Midwest Heart
Research Foundation, Lombard, IL, USA
Congestive heart failure (CHF) is the most frequent reason for admission
to the hospital. The management of these patients is frequently directed by
the family practitioner (FP) or medical internist (lM). Several studies have
confirmed that CHF patients cared for by FP or IM have longer lengths of
stay and more costly stays than CHF petients managed by cardiologists
(CD). Accordingly, we instituted an intensive education program directed
(EP) for the FP/lM based on American College of Cardiology/American Hearl
Association (ACC/AHA) guidelines for the management of CHF to alter this
pattern. The EP was not provided to CD to allow the group to sewe as a
control. Data on the mean length of stay (LOS) (s’= p .=0.05) and the mean
cost per case (o = p < 0.05) associated with these hospitalizations in patients
managed by IM, FP,snd CD prior to the provision of the EP (IM n = 105: FP
n = 373; CD n = 77) and following the EP (IM n = 64; FP n = 329; CD n = 71)
